Advocacy intelligence hub — real-time data for patient organizations
Betapace: FDA approved
Treatment of life-threatening ventricular tachyarrhythmias
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Betapace
Berlex Laboratories, Inc.
Browse all Double outlet right ventricle with subpulmonary ventricular septal defect news →
View all Double outlet right ventricle with subpulmonary ventricular septal defect specialists →